Palau Healthcare Times: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Palau Healthcare Times.

Press releases published on August 18, 2026

4 hours ago

Eyconis Announces Initiation of First-in-Human Clinical Trial of EYC-0305 in Treatment-Naïve Wet Age-Related Macular Degeneration Patients

Indeterminate GlobeNewswire

4 hours ago

Elutia Completes SimpliDerm® Sale on Schedule, Adds $8 Million in Cash to Fund NXT-41x Through Full Commercial Launch

Indeterminate GlobeNewswire

4 hours ago

Entera Appoints Global Pharmaceutical Leader Riccardo Paolo Camisasca, M.D., as Chief Medical Officer Ahead of Planned EB613 Phase 3 Initiation

Indeterminate GlobeNewswire

4 hours ago

PROMIXX Pursuit Insulated Shaker Bottle Keeps Protein Shakes Ice Cold for 12+ Hours, Outlasting Standard Gym Bottles

Indeterminate GlobeNewswire

4 hours ago

AVITA Medical Announces Positive PermeaDerm® Study Results Demonstrating 70% Economic Advantage over Allograft and Comparable Clinical Outcomes

Indeterminate GlobeNewswire

4 hours ago

BrewDog Unwraps Its 2026 Advent Calendar

Indeterminate GlobeNewswire

4 hours ago

Helus Pharma Appoints Regina Donohue as Chief People Officer and Suresh Durgam, M.D., to its Scientific Advisory Board

Indeterminate GlobeNewswire

4 hours ago

Prenetics’ IM8 Reports Q2 2026 Revenue Growth of 288% YoY; Raises FY 2026 IM8 Revenue Guidance to $220–230 Million; July Was the First Month of Positive Consolidated Adjusted Free Cash Flow and Expected to Remain Positive for Q3 and Beyond

Indeterminate GlobeNewswire

4 hours ago

General Oncology Nominated for the 2026 Prix Galien USA Best Startup Award

Indeterminate GlobeNewswire

5 hours ago

CHARM Therapeutics announces formation of Clinical Advisory Board to support advancement of CHM-029, its next-generation menin inhibitor

Indeterminate GlobeNewswire

5 hours ago

Immatics Announces Second Quarter 2026 Financial Results and Business Update

Indeterminate GlobeNewswire

5 hours ago

ABBYY’s New Executive Appointments Illustrate Focus on Hybrid AI to Drive Enterprise Intelligence

Indeterminate GlobeNewswire

5 hours ago

Tilray Medical Welcomes Progress in Germany’s Medical Cannabis Framework and Supports Continued Policy Development

Indeterminate GlobeNewswire

5 hours ago

Tilray Medical begrüßt die positiven Entwicklungen im deutschen Rechtsrahmen für medizinisches Cannabis und setzt sich für dessen kontinuierliche Weiterentwicklung ein

Indeterminate GlobeNewswire

5 hours ago

Asimov Announces Cell Line Development Partnership with Kaigene to Advance Multispecific Antibody for Autoimmune Disease

Indeterminate GlobeNewswire

5 hours ago

BlossomHill Therapeutics Announces FDA Fast Track Designation for BH-30643, a Macrocyclic OMNI-EGFR™ Inhibitor for the Treatment of Advanced EGFR C797S-positive NSCLC

Indeterminate GlobeNewswire

9 hours ago

Smith+Nephew and Imperial College London launch centre to accelerate innovation in surgical robotics

Indeterminate GlobeNewswire

9 hours ago

Coultreon Biopharma Appoints Prista Charuworn, MD as Chief Medical Officer

Indeterminate GlobeNewswire

9 hours ago

Cloud 9 Vets calls on the CMA to add at-home pet euthanasia to the new mandatory vet price list

Indeterminate GlobeNewswire

10 hours ago

Basilea erzielt starkes Halbjahresergebnis 2026 und erhöht die Finanzprognose für das Gesamtjahr; Phase-3-Programm mit Fosmanogepix auf Kurs

Indeterminate GlobeNewswire